• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Refractory Sweet Syndrome Treated with Anakinra.用阿那白滞素治疗难治性Sweet综合征。
Cureus. 2019 Apr 24;11(4):e4536. doi: 10.7759/cureus.4536.
2
Neutrophilic dermatoses: a review of current treatment options.嗜中性皮肤病:当前治疗选择综述
Am J Clin Dermatol. 2009;10(5):301-12. doi: 10.2165/11310730-000000000-00000.
3
Histiocytoid Sweet Syndrome in a Child without Underlying Systemic Disease.无潜在系统性疾病儿童的组织细胞样Sweet综合征
Ann Dermatol. 2017 Oct;29(5):626-629. doi: 10.5021/ad.2017.29.5.626. Epub 2017 Aug 25.
4
[Cutaneous Manifestations of Sweet Disease].[Sweet病的皮肤表现]
Brain Nerve. 2019 Apr;71(4):334-338. doi: 10.11477/mf.1416201271.
5
Recurrent Malignancy-Associated Atypical Neutrophilic Dermatosis With Noninfectious Shock.复发性恶性肿瘤相关性非感染性休克伴非典型嗜中性皮病
Am J Med Sci. 2017 Dec;354(6):626-632. doi: 10.1016/j.amjms.2016.10.003. Epub 2016 Oct 20.
6
[Acute febrile neutrophilic dermatosis - Sweet syndrome].[急性发热性嗜中性皮病 - 斯威特综合征]
Cas Lek Cesk. 2012;151(7):359-61.
7
Sweet outcome for a rare inflammatory condition.一种罕见炎症性疾病的良好结果。
N Z Med J. 2016 Feb 19;129(1430):89-93.
8
Sweet syndrome in infancy.婴儿期Sweet综合征
Pediatr Dermatol. 2010 Mar-Apr;27(2):208-9. doi: 10.1111/j.1525-1470.2010.01113.x.
9
A Rare Case of Drug-Induced Sweet Syndrome After Pembrolizumab Therapy.帕博利珠单抗治疗后发生药物性Sweet综合征1例罕见病例
Cureus. 2024 Jun 9;16(6):e62027. doi: 10.7759/cureus.62027. eCollection 2024 Jun.
10
An uncommon ocular manifestation of Sweet syndrome: peripheral ulcerative keratitis and nodular scleritis.Sweet综合征一种罕见的眼部表现:周边溃疡性角膜炎和结节性巩膜炎。
Arq Bras Oftalmol. 2015 Jan-Feb;78(1):53-5. doi: 10.5935/0004-2749.20150015.

引用本文的文献

1
Palliative oncodermatology: Management of malignancy-related cutaneous symptoms in the palliative care setting.姑息性肿瘤皮肤病学:姑息治疗环境中恶性肿瘤相关皮肤症状的管理。
J Am Acad Dermatol. 2025 Jun;92(6):1351-1359. doi: 10.1016/j.jaad.2025.02.021. Epub 2025 Feb 13.
2
Molecular Characteristics of Sweet Syndrome: A Systematic Review.Sweet综合征的分子特征:一项系统综述
Exp Dermatol. 2024 Dec;33(12):e70022. doi: 10.1111/exd.70022.
3
Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review.中性粒细胞皮肤病的治疗策略:全面综述。
Int J Mol Sci. 2023 Oct 26;24(21):15622. doi: 10.3390/ijms242115622.
4
Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome.鉴定出中性粒细胞特异性 PIK3R1 突变,有助于对Sweet 综合征患者进行靶向治疗。
J Clin Invest. 2023 Jan 3;133(1):e162137. doi: 10.1172/JCI162137.
5
Neutrophilic Dermatoses: a Clinical Update.嗜中性皮肤病:临床最新进展
Curr Dermatol Rep. 2022;11(2):89-102. doi: 10.1007/s13671-022-00355-8. Epub 2022 Mar 16.
6
New Practical Aspects of Sweet Syndrome.Sweet 综合征的新实用方面。
Am J Clin Dermatol. 2022 May;23(3):301-318. doi: 10.1007/s40257-022-00673-4. Epub 2022 Feb 14.
7
Off-label use of anti-IL-1 drugs in rheumatic diseases.抗白细胞介素-1 药物在风湿性疾病中的超适应证使用。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211006584. doi: 10.1177/20587384211006584.
8
Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy.对合并和未合并血液系统恶性肿瘤患者的Sweet综合征特征的见解。
Front Med (Lausanne). 2020 Feb 18;7:20. doi: 10.3389/fmed.2020.00020. eCollection 2020.

本文引用的文献

1
Histiocytoid Sweet syndrome successfully treated with etanercept.用依那西普成功治疗组织细胞样Sweet综合征。
Proc (Bayl Univ Med Cent). 2018 May 9;31(3):347-349. doi: 10.1080/08998280.2018.1460132. eCollection 2018 Jul.
2
Sweet syndrome after treatment with vedolizumab in a patient with Crohn's disease.一名克罗恩病患者使用维多珠单抗治疗后出现Sweet综合征。
Rev Esp Enferm Dig. 2018 Aug;110(8):530. doi: 10.17235/reed.2018.5603/2018.
3
Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.采用粒细胞和单核细胞吸附性血液成分分离术成功治疗Sweet综合征。
Case Rep Dermatol. 2017 May 22;9(2):13-18. doi: 10.1159/000475878. eCollection 2017 May-Aug.
4
Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.用阿达木单抗治疗难治性皮下Sweet综合征。
JAMA Dermatol. 2016 Jul 1;152(7):842-4. doi: 10.1001/jamadermatol.2016.0503.
5
Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.利妥昔单抗治疗慢性淋巴细胞白血病难治性皮下Sweet综合征:一例报告
Mol Clin Oncol. 2016 Mar;4(3):436-440. doi: 10.3892/mco.2015.715. Epub 2015 Dec 18.
6
Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients.Sweet 综合征:77 例患者的临床表现、相关因素及治疗反应。
J Am Acad Dermatol. 2013 Oct;69(4):557-64. doi: 10.1016/j.jaad.2013.06.023. Epub 2013 Jul 23.
7
Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome.抗白细胞介素-1 受体拮抗剂阿那白滞素(凯那®)治疗难治性Sweet 综合征 1 例
Dermatology. 2011;222(2):123-7. doi: 10.1159/000326112. Epub 2011 Apr 5.
8
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.白细胞介素-1受体拮抗剂阿那白滞素治疗难治性Sweet综合征的疗效
Ann Rheum Dis. 2008 Feb;67(2):278-9. doi: 10.1136/ard.2006.068254.
9
Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.斯威特综合征——急性发热性嗜中性皮病的全面综述
Orphanet J Rare Dis. 2007 Jul 26;2:34. doi: 10.1186/1750-1172-2-34.
10
Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor.难治性Sweet 综合征伴自身免疫性机化性肺炎,用肿瘤坏死因子单克隆抗体治疗。
J Clin Rheumatol. 2004 Dec;10(6):331-5. doi: 10.1097/01.rhu.0000147053.60795.46.

用阿那白滞素治疗难治性Sweet综合征。

Refractory Sweet Syndrome Treated with Anakinra.

作者信息

Shahid Zainab, Kalayanamitra Ricci, Patel Ravi, Groff Andrew, Jain Rohit

机构信息

Internal Medicine, Lake Erie College of Osteopathic Medicine, Erie, USA.

Emergency Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.

出版信息

Cureus. 2019 Apr 24;11(4):e4536. doi: 10.7759/cureus.4536.

DOI:10.7759/cureus.4536
PMID:31263644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6592472/
Abstract

Sweet syndrome, otherwise known as acute febrile neutrophilic dermatosis, is an uncommon disorder characterized by the abrupt onset of painful cutaneous lesions, often with fever and leukocytosis, in patients with underlying infection, malignancy, pregnancy, or drug exposure. We present a case of a young female with long-standing Sweet syndrome refractory to standard treatments and several immunomodulators whose symptoms were ultimately controlled with anakinra.

摘要

斯威特综合征,又称急性发热性嗜中性皮病,是一种罕见的疾病,其特征为在患有潜在感染、恶性肿瘤、妊娠或接触药物的患者中,突然出现疼痛性皮肤病变,常伴有发热和白细胞增多。我们报告一例年轻女性患者,患有长期难治性斯威特综合征,对标准治疗和多种免疫调节剂均无反应,其症状最终通过阿那白滞素得到控制。